509 related articles for article (PubMed ID: 34298819)
21. The Functions of BET Proteins in Gene Transcription of Biology and Diseases.
Cheung KL; Kim C; Zhou MM
Front Mol Biosci; 2021; 8():728777. PubMed ID: 34540900
[TBL] [Abstract][Full Text] [Related]
22. Alternative Mechanisms for DNA Engagement by BET Bromodomain-Containing Proteins.
Kalra P; Zahid H; Ayoub A; Dou Y; Pomerantz WCK
Biochemistry; 2022 Jul; 61(13):1260-1272. PubMed ID: 35748495
[TBL] [Abstract][Full Text] [Related]
23. Recent progress and structural analyses of domain-selective BET inhibitors.
Divakaran A; Harki DA; Pomerantz WCK
Med Res Rev; 2023 Jul; 43(4):972-1018. PubMed ID: 36971240
[TBL] [Abstract][Full Text] [Related]
24. The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes.
Langini C; Caflisch A; Vitalis A
J Biol Chem; 2017 Oct; 292(40):16734-16745. PubMed ID: 28798233
[TBL] [Abstract][Full Text] [Related]
25. BET Bromodomain as a Target of Epigenetic Therapy.
Noguchi-Yachide T
Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
[TBL] [Abstract][Full Text] [Related]
26. The BRPF1 bromodomain is a molecular reader of di-acetyllysine.
Obi JO; Lubula MY; Cornilescu G; Henrickson A; McGuire K; Evans CM; Phillips M; Boyson SP; Demeler B; Markley JL; Glass KC
Curr Res Struct Biol; 2020; 2():104-115. PubMed ID: 33554132
[TBL] [Abstract][Full Text] [Related]
27. Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.
Olp MD; Zhu N; Smith BC
Biochemistry; 2017 Oct; 56(41):5485-5495. PubMed ID: 28945351
[TBL] [Abstract][Full Text] [Related]
28. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
[TBL] [Abstract][Full Text] [Related]
29. The bromodomain of Gcn5 regulates site specificity of lysine acetylation on histone H3.
Cieniewicz AM; Moreland L; Ringel AE; Mackintosh SG; Raman A; Gilbert TM; Wolberger C; Tackett AJ; Taverna SD
Mol Cell Proteomics; 2014 Nov; 13(11):2896-910. PubMed ID: 25106422
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain-containing factors.
Gold S; Shilatifard A
Curr Opin Genet Dev; 2024 Apr; 86():102181. PubMed ID: 38564841
[TBL] [Abstract][Full Text] [Related]
31. Bromodomains: Translating the words of lysine acetylation into myelin injury and repair.
Ntranos A; Casaccia P
Neurosci Lett; 2016 Jun; 625():4-10. PubMed ID: 26472704
[TBL] [Abstract][Full Text] [Related]
32. Specific Acetylation Patterns of H2A.Z Form Transient Interactions with the BPTF Bromodomain.
Perell GT; Mishra NK; Sudhamalla B; Ycas PD; Islam K; Pomerantz WCK
Biochemistry; 2017 Sep; 56(35):4607-4615. PubMed ID: 28771339
[TBL] [Abstract][Full Text] [Related]
33. Functional networks of the human bromodomain-containing proteins.
Gao C; Glass KC; Frietze S
Front Bioinform; 2022; 2():835892. PubMed ID: 36304339
[No Abstract] [Full Text] [Related]
34. Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3.
Gamsjaeger R; Webb SR; Lamonica JM; Billin A; Blobel GA; Mackay JP
Mol Cell Biol; 2011 Jul; 31(13):2632-40. PubMed ID: 21555453
[TBL] [Abstract][Full Text] [Related]
35. Cooperative binding of two acetylation marks on a histone tail by a single bromodomain.
Morinière J; Rousseaux S; Steuerwald U; Soler-López M; Curtet S; Vitte AL; Govin J; Gaucher J; Sadoul K; Hart DJ; Krijgsveld J; Khochbin S; Müller CW; Petosa C
Nature; 2009 Oct; 461(7264):664-8. PubMed ID: 19794495
[TBL] [Abstract][Full Text] [Related]
36. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
Hewings DS; Wang M; Philpott M; Fedorov O; Uttarkar S; Filippakopoulos P; Picaud S; Vuppusetty C; Marsden B; Knapp S; Conway SJ; Heightman TD
J Med Chem; 2011 Oct; 54(19):6761-70. PubMed ID: 21851057
[TBL] [Abstract][Full Text] [Related]
37. A bromodomain-DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT.
Miller TC; Simon B; Rybin V; Grötsch H; Curtet S; Khochbin S; Carlomagno T; Müller CW
Nat Commun; 2016 Dec; 7():13855. PubMed ID: 27991587
[TBL] [Abstract][Full Text] [Related]
38. Targeting bromodomains: epigenetic readers of lysine acetylation.
Filippakopoulos P; Knapp S
Nat Rev Drug Discov; 2014 May; 13(5):337-56. PubMed ID: 24751816
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence.
Chaidos A; Caputo V; Karadimitris A
Ther Adv Hematol; 2015 Jun; 6(3):128-41. PubMed ID: 26137204
[TBL] [Abstract][Full Text] [Related]
40. The role of bromodomain proteins in regulating gene expression.
Josling GA; Selvarajah SA; Petter M; Duffy MF
Genes (Basel); 2012 May; 3(2):320-43. PubMed ID: 24704920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
